Liontrust Investment Partners LLP Reduces Stake in Intuitive Surgical, Inc. $ISRG

Key Points

• Liontrust Investment Partners LLP reduced its stake in Intuitive Surgical by 6.2% in Q1, owning 271,116 shares after selling 17,798 shares during the period.
• Intuitive Surgical reported $2.19 EPS for the last quarter, surpassing the consensus estimate of $1.93, with a revenue of $2.44 billion, up 21.4% year-over-year.
• Multiple hedge funds have recently modified their holdings in Intuitive Surgical, with Dimensional Fund Advisors LP increasing its stake by 1.5% to 574,954 shares worth $284.7 million.

Liontrust Investment Partners LLP reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 271,116 shares of the medical equipment provider's stock after selling 17,798 shares during the quarter. Intuitive Surgical comprises 2.1% of Liontrust Investment Partners LLP's portfolio, making the stock its 11th biggest position. Liontrust Investment Partners LLP owned 0.08% of Intuitive Surgical worth $134,276,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Brighton Jones LLC raised its stake in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after purchasing an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG lifted its stake in shares of Intuitive Surgical by 0.5% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after buying an additional 883 shares during the last quarter. Evergreen Capital Management LLC lifted its stake in shares of Intuitive Surgical by 2.7% during the 4th quarter. Evergreen Capital Management LLC now owns 4,268 shares of the medical equipment provider's stock worth $2,228,000 after buying an additional 112 shares during the last quarter. Main Street Financial Solutions LLC lifted its stake in shares of Intuitive Surgical by 82.0% during the 4th quarter. Main Street Financial Solutions LLC now owns 2,808 shares of the medical equipment provider's stock worth $1,466,000 after buying an additional 1,265 shares during the last quarter. Finally, Farringdon Capital Ltd. bought a new position in Intuitive Surgical during the 4th quarter worth $395,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares of the company's stock, valued at $510,740.77. This trade represents a 19.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gary S. Guthart sold 7,893 shares of the firm's stock in a transaction that occurred on Monday, July 28th. The shares were sold at an average price of $498.64, for a total value of $3,935,765.52. Following the transaction, the insider directly owned 13,187 shares of the company's stock, valued at approximately $6,575,565.68. This trade represents a 37.44% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,839 shares of company stock valued at $7,896,972. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 0.7%

Shares of NASDAQ:ISRG traded up $3.18 during midday trading on Friday, reaching $480.26. 1,436,064 shares of the company traded hands, compared to its average volume of 2,169,233. The firm has a market capitalization of $172.16 billion, a price-to-earnings ratio of 66.98, a price-to-earnings-growth ratio of 5.03 and a beta of 1.59. The firm's fifty day moving average price is $508.75 and its two-hundred day moving average price is $524.77. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The company had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same period in the prior year, the business posted $1.78 EPS. Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft cut Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price objective for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Barclays lowered their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Citigroup reiterated a "buy" rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. BTIG Research raised their price target on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Finally, Wells Fargo & Company raised their price target on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.